For a general review of the disease itself, current medical consensus highlights several key areas:
(PDF) Optimizing Mendelian Randomization for Drug Prediction leukemia - Mr Validity
The phrase "" most likely refers to the use of Mendelian Randomization (MR) to evaluate the validity of causal relationships and drug targets in leukemia research . For a general review of the disease itself,
: Recent reviews indicate that MR models have approximately 70% accuracy in predicting effective drug targets. Clinical Overview of Leukemia : A 2026 study
If you are referring to the of a specific clinical measurement tool like the EQ-5D (a health questionnaire used by leukemia patients), reviews show it has high "known-groups validity"—meaning it accurately discriminates between patients based on age, education, and treatment severity. Clinical Overview of Leukemia
: A 2026 study used proteome-wide MR to identify 27 circulating proteins associated with B-cell malignancy risk, pinpointing 23 potential drug targets .